Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Small white dots on the scalp seen with a dermoscope correspond to sweat ducts and vary with different hair disorders.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Dermoscopic examination helps diagnose different types of hair loss conditions by showing specific patterns.

Both intense pulsed light and long-pulsed diode laser effectively reduced facial hair in women, with no significant difference in satisfaction after 6 months, but intense pulsed light was more painful.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Lipid peroxidation worsens skin diseases but may help treat cancer.

Bald men may have higher heart disease risk.

Lichen planus is linked to several autoimmune diseases.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.